Author:
Segal Shelley,Snape Matthew,Kelly Dominic,Pollard Andrew J.
Reference145 articles.
1. Levine OS, Schwartz B, Pierce N, Kane M. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for young children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998;17(9 suppl): S95–113.
2. Herson VC, Todd JK. Prediction of morbidity in Haemophilus influenzae meningitis. Pediatrics 1977;59(1):35–39.
3. Peltola H, Kayhty H, Sivonen A, Makela H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977;60(5):730–737.
4. Heath PT. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data. Pediatr Infect Dis J 1998;17(9 suppl):S117–122.
5. Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000;31(4):973–980.